傳染病診斷測試的全球市場

本報告調查了全球傳染病診斷檢測市場，並提供了市場概況，以及產品趨勢、區域趨勢和進入市場的公司概況。

目錄

第 1 章執行摘要

第二章市場環境

• 概覽
• 人口
• 年齡分佈
• 宏觀經濟環境
• 全球經濟展望
• 人均國內生產總值
• 全球醫療保健趨勢
• 傳染病病例
• 醫療保健提供者
• 患者活動
• 住院
• 住院時間
• 外科手術
• 門診諮詢
• 體外診斷測試

第三章傳染病體外診斷產品和市場

• 概覽
• 性傳播疾病 (STI)
• 沙眼衣原體(Chlamydia)
• 人乳頭瘤病毒（HPV）
• 淋病
• 單純皰疹病毒2（HSV-2）
• 梅毒
• 其他性傳播疾病 (STD) 體外診斷產品
• 醫療相關傳染病
• 艱難梭菌 (C. diff)
• 敗血症
• 耐甲氧西林金黃色葡萄球菌（MRSA）
• 耐萬古黴素腸球菌（VRE）
• 其他 HAI
• 鑑定和抗生素藥敏試驗 (ID/AST) 產品
• 自動識別/AST 產品
• 手動面板和試劑
• 製片人
• IVD肝炎產品
• HIV/AIDS IVD產品
• 流感
• 結核病 (TB)
• 火炬
• 所有其他傳染病IVD產品
• 新冠肺炎 (COVID-19)
• 世界傳染病IVD技術
• 免疫學檢查
• 分子技術
• 傳統微生物學
• 按市場分列的全球傳染病 IVD 需求

第 4 章世界市場

• 概覽
• 北美
• 美國
• 加拿大
• 墨西哥
• 西歐
• 德國
• 法國
• 英國
• 意大利
• 西班牙
• 其他西歐國家
• 亞太地區
• 中國
• 印度
• 日本
• 韓國
• 其他亞太國家
• 其他領域
• 拉丁美洲
• 巴西
• 阿根廷
• 哥倫比亞
• 秘魯
• 智利
• 非洲/中東
• 土耳其
• 沙特阿拉伯
• 伊朗
• 埃及
• 伊拉克
• 尼日利亞
• 南非
• 以色列
• 阿拉伯聯合酋長國
• 所有其他國家和地區

第 5 章公司簡介

• Abbott Laboratories
• Becton Dickinson and Company
• Bio-Rad Laboratories
• bioM?rieux
• Bruker Corporation
• Danaher Corporation
• DiaSorin
• Grifols S.A.
• Hologic
• Ortho Clinical Diagnostics Holdings
• QIAGEN
• Quidel Corporation
• Roche Holding
• Siemens Healthineers
• Thermo Fisher Scientific

Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the responsible pathogen, pinpoint its origin, and determine an appropriate antimicrobial therapy.

Infectious disease IVD products include reagents, consumables, and instruments based primarily on immunoassays, molecular technologies, and conventional microbiology techniques. Specific types of tests are available for detecting hundreds of pathogenic conditions. The report examines the global demand for infectious disease IVD products, which is projected to increase as medical providers and healthcare organizations throughout the world heighten efforts to combat proliferating epidemic threats.

This report, “Infectious Disease Diagnostic Testing: World Market Analysis”, examines the global market for infectious disease testing products. Specific applications analyzed include:

• Healthcare-associated and opportunistic infections

• Antimicrobial-resistant pathogens including bacteria, fungi, parasites, and viruses

• Human immunodeficiency virus (HIV) and hepatitis viruses

• Diseases related to women's health and sexually transmitted infections (STDs)

• Emerging, neglected, and tropical disease threats

• Respiratory tract infections and respiratory viruses (including COVID-19)

Geographic and Country Markets

Opportunities for infectious disease testing products vary widely between the developed and developing countries. Regions covered include:

Market Drivers

The report examines market drivers, including external market influences that are promoting the development and use of improved infectious disease diagnostics. Public health officials worldwide have begun to recognize the global nature of infectious diseases - they are no longer solely a problem of developing countries but touch the very fabric of the social and economic welfare of countries in the industrialized world as well. Over the long term, aging populations and problems posed by infectious diseases will strain healthcare resources in many countries.

Competitive Landscape

The report details the major competitors that are global market leaders in infectious disease testing products and technologies, including an overview and an outline of these company's infectious disease IVD products:

The information presented herein is derived from publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and selected direct interviews with industry experts conducted previously.

Estimates in the report are based on an examination of epidemiological statistics, test pricing, annual reports of key competitors and regional sales, as well as Kalorama Information's databases and economic composites. Forecasts presented for Eastern Europe were prepared prior to Russia's invasion of Ukraine and its negative impact on the healthcare systems of both countries.

Table of Contents

Chapter 1: Executive Summary

• A Mix of Traditional and Emerging Testing Technologies
• Market Drivers
• The World Infectious Disease Testing Market
  • Table 1-1a: World Infectious Disease Diagnostic Test Market, 2018-2026 ($ millions)
  • Table 1-1b: World Infectious Disease Diagnostic Test Market, 2027-2031 ($ millions)
• Major Findings of the Report
  • Table 1-2: Selected Infectious Diseases, Global Incidence, Prevalence, & Mortality, 2021
• Scope and Methodology

Chapter 2: Market Environment

• Overview
• Population
  • Table 2-1a: Population by Country, 2018-2025 (million)
  • Table 2-1b: Population by Country, 2026-2031 (million)
• Age Distribution
  • Table 2-2a: Population 50 Years & Older by Country, 2018-2025 (million)
  • Table 2-2b: Population 50 Years & Older by Country, 2026-2031 (million)
  • Table 2-3a: Population 65 Years & Older by Country, 2018-2025 (million)
  • Table 2-3b: Population 65 Years & Older by Country, 2026-2031 (million)
• Macroeconomic Environment
• Global Economic Outlook
  • Table 2-4a: Gross Domestic Product by Country, 2018-2025 (billion dollars)
  • Table 2-4b: Gross Domestic Product by Country, 2026-2031 (billion dollars)
• Per Capita Gross Domestic Product
  • Table 2-5a: Per Capita Gross Domestic Product by Country, 2018-2025 (dollars)
  • Table 2-5b: Per Capita Gross Domestic Product by Country, 2026-2031 (dollars)
• Global Healthcare Trends
• Infectious Disease Cases
  • Table 2-6a: Number of Infectious Disease Cases by Country, 2018-2025 (million)
  • Table 2-6b: Number of Infectious Disease Cases by Country, 2026-2031 (million)
  • Table 2-7a: Health Expenditures by Country, 2018-2025 (billion dollars)
  • Table 2-7b: Health Expenditures by Country, 2026-2031 (billion dollars)
• Medical Providers
  • Table 2-8 Medical Providers, Selected Countries, 2021
• Patient Activity
• Hospital Admissions
  • Table 2-9a: Hospital Admissions by Country, 2018-2025 (million)
  • Table 2-9b.: Hospital Admissions by Country, 2026-2031 (million)
• Inpatient Days
  • Table 2-10a: Inpatient Days by Country, 2018-2025 (million)
  • Table 2-10b: Inpatient Days by Country, 2026-2031 (million)
• Surgical Procedures
  • Table 2-11a: Surgical Procedures by Country, 2018-2025 (million)
  • Table 2-11b: Surgical Procedures by Country, 2026-2031 (million)
• Outpatient Consultations
  • Table 2-12a: Outpatient Consultations by Country, 2018-2025 (million)
  • Table 2-12b: Outpatient Consultations by Country, 2026-2031 (million)
• IVD Tests
  • Table 2-13a: IVD Tests by Country, 2018-2025 (million)
  • Table 2-13b: IVD Tests by Country, 2026-2031 (million)

Chapter 3: Infectious Disease IVD Products & Markets

• Overview
  • Table 3-1a: Global Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 3-1b: Global Infectious Disease IVD Products Demand by Type, 2026-2031 (million dollars)
• Sexually Transmitted Infections (STIs)
  • Table 3-2a: Global Sexually Transmitted Infection IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-2b: Global Sexually Transmitted Infections IVD Products Demand, 2026-2031 (million dollars)
• Chlamydia Trachomatis (chlamydia)
• Human Papillomavirus (HPV)
• Gonorrhea
• Herpes Simplex Virus 2 (HSV-2)
• Syphilis
• Other Sexually Transmitted Disease (STD) IVD Products
• Healthcare-Associated Infections
  • Table 3-3a: Global Healthcare-Associated Infection IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-3b: Global Healthcare-Associated Infections IVD Products Demand, 2026-2031 (million dollars)
• Clostridium difficile (C. diff)
• Sepsis
• Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Vancomycin-Resistant Enterococcus (VRE)
• Other HAIs
• Identification & Antibiotic Susceptibility Testing (ID/AST) Products
  • Table 3-4a: Global ID/AST IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-4b: Global ID/AST IVD Products Demand, 2026-2031 (million dollars)
• Automated ID/AST Products
• Manual Panels & Reagents
• Producers
• Hepatitis IVD Products
  • Table 3-5a: Global Hepatitis IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-5b: Global Hepatitis IVD Products Demand, 2026-2031 (million dollars)
• HIV/AIDS IVD Products
  • Table 3-6a: Global HIV/AIDS IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-6b: Global HIV/AIDS IVD Products Demand, 2026-2031 (million dollars)
• Influenza
  • Table 3-7a: Global Influenza IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-7b: Global Influenza IVD Products Demand, 2026-2031 (million dollars)
• Tuberculosis (TB)
  • Table 3-8a: Global Tuberculosis IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-8b: Global Tuberculosis IVD Products Demand, 2026-2031 (million dollars)
• TORCH
  • Table 3-9a: Global TORCH IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-9b: Global TORCH IVD Products Demand, 2026-2031 (million dollars)
• All Other Infectious Disease IVD Products
  • Table 3-10a: Global Other Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-10b: Global Other Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Malaria
• Streptococcal Infections
• Fungal Infections
• Parasitic Conditions
• Lyme Disease
• Respiratory Syncytial Virus (RSV)
• Emerging Infections
• Chikungunya
• Dengue Fever
• Additional Products
• COVID-19
  • Table 3-11 Global COVID-19 IVD Products Demand, 2018-2026 (million dollars)
• Global Infectious Disease IVD Technologies
  • Table 3-12a: Global Infectious Disease IVD Products Demand by Technology, 2018-2025 (million dollars)
  • Table 3-12b: Global Infectious Disease IVD Products Demand by Technology, 2026-2031 (million dollars)
• Immunoassays
  • Table 3-13a: Global Immunoassay Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-13b: Global Immunoassay Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Molecular Technologies
  • Table 3-14a: Global Molecular Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-14b: Global Molecular Infectious Disease IVD Products Demand 2026-2031 (million dollars)
• Conventional Microbiology
  • Table 3-15a: Global Microbiology Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-15b: Global Microbiology Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Global Infectious Disease IVD Demand by Market
  • Table 3-16a: Global Infectious Disease IVD Products Demand by Site, 2018-2025 (million dollars)
  • Table 3-16b: Global Infectious Disease IVD Products Demand by Site, 2026-2031 (million dollars)
  • Table 3-17a: Global Laboratory Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-17b: Global Laboratory Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
  • Table 3-18a: Global Point-of-Care Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 3-18b: Global Point-of-Care Infectious Disease IVD Products Demand, 2026-2031 (million dollars)

Chapter 4: Global Markets

• Overview
  • Table 4-1a: Infectious Disease IVD Products Demand by Country, 2018-2025 (million dollars)
  • Table 4-1b: Infectious Disease IVD Products Demand by Country/Region, 2026-2031 (million dollars)
• North America
  • Table 4-2a: North America: Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
  • Table 4-2b: North America: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• United States
  • Table 4-3a: United States: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-3b: United States: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Canada
  • Table 4-4a: Canada: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-4b: Canada: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Mexico
  • Table 4-5a: Mexico: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-5b: Mexico: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Western Europe
  • Table 4-6a: Western Europe: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-6b: Western Europe: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Germany
  • Table 4-7a: Germany: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-7b: Germany: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• France
  • Table 4-8a: France: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-8b: France: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• United Kingdom
  • Table 4-9a: United Kingdom: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-9b: United Kingdom: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Italy
  • Table 4-10a: Italy: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-10b: Italy: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Spain
  • Table 4-11a: Spain: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-11b: Spain: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Other Western Europe
  • Table 4-12a: Other Western Europe: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-12b: Other Western Europe: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Netherlands
• Belgium
• Sweden
• Austria
• Switzerland
• Norway
• Denmark
• Portugal
• Ireland
• Greece
• Finland
• All Other Countries & Territories
• Asia/Pacific
  • Table 4-13a: Asia/Pacific: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-13b: Asia/Pacific: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• China
  • Table 4-14a: China: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-14b: China: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• India
  • Table 4-15a: India: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-15b: India: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Japan
  • Table 4-16a: Japan: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-16b: Japan: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• South Korea
  • Table 4-17a: South Korea: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-17b: South Korea: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Other Asia/Pacific
  • Table 4-18a: Other Asia/Pacific: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-18b: Other Asia/Pacific: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Indonesia
• Australia
• Philippines
• Thailand
• Taiwan
• Vietnam
• Malaysia
• Pakistan
• Hong Kong
• Singapore
• New Zealand
• All Other Countries & Territories
• Other Regions
  • Table 4-19a: Other Regions: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-19b: Other Regions: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Central & South America
  • Table 4-20a: Central & South America: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-20b: Central & South America: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Brazil
• Argentina
• Colombia
• Peru
• Chile
• All Other Countries & Territories
• Eastern Europe
  • Table 4-21a: Eastern Europe: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-21b: Eastern Europe: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Russia
• Poland
• Romania
• Czech Republic
• Hungary
• All Other Countries
• Africa/Middle East
  • Table 4-22a: Africa/Middle East: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
  • Table 4-22b: Africa/Middle East: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
• Turkey
• Saudi Arabia
• Iran
• Egypt
• Iraq
• Nigeria
• South Africa
• Israel
• United Arab Emirates
• All Other Countries & Territories

Chapter 5: Company Profiles

• Abbott Laboratories
• Becton Dickinson and Company
• Bio-Rad Laboratories
• bioMérieux
• Bruker Corporation
• Danaher Corporation
• DiaSorin
• Grifols S.A.
• Hologic
• Ortho Clinical Diagnostics Holdings
• QIAGEN
• Quidel Corporation
• Roche Holding
• Immunoassays
• COVID-19
• Siemens Healthineers
• Thermo Fisher Scientific
• Microbiology
• COVID-19